Stockscreener 앱 받기
91.79
0.46%
-0.42
시장 영업 전:
90.34
-1.45
-1.58%
Edwards Lifesciences Corp 주식(EW)의 최신 뉴스
Edwards Lifesciences, Genesis MedTech to Pay Combined $12M to Settle FTC Charges -- Update - Moomoo
Edwards Lifesciences to pay record $10m for HSR evasion - Global Competition Review
Form 4 Edwards Lifesciences Corp For: 13 July By Investing.com - Investing.com Nigeria
Edwards Lifesciences, Genesis Medtech to pay $12m for HSR noncompliance - MLex
RBC Raises Price Target on Edwards Lifesciences to $110 From $100, Keeps Outperform Rating - marketscreener.com
Edwards Lifesciences stock reflects steady growth prospects in cardiovascular care - ad-hoc-news.de
Edwards Lifesciences stands out as US agency eyes broader access for heart valve device - MSN
Edwards Lifesciences CVP sells $56,762 in company stock - Investing.com UK
Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW) - GuruFocus
EW News | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill
Form 4 Edwards Lifesciences Corp For: 10 July By Investing.com - Investing.com India
Edwards Lifesciences CVP sells $56,762 in company stock By Investing.com - Investing.com Canada
Edwards Lifesciences (EW) CFO receives stock, performance unit and option grants - Stock Titan
Edwards Lifesciences (NYSE: EW) CVP exercises stock options and sells 619 shares - Stock Titan
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors - MarketWatch
TRiCares Announces Initiation of TRICURE US IDE Pivotal Study for Topaz Tricuspid Valve Replacement System - GlobeNewswire Inc.
Edwards Lifesciences highlights structural heart portfolio as investors track long-term growth - ad-hoc-news.de
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Edwards Lifesciences (NYSE:EW) Valve Data Keeps Healthcare Focus - Kalkine Media
Edwards Lifesciences focuses on heart valve growth as US cardiac demand stays solid - ad-hoc-news.de
The Edwards SAPIEN 3 Ultra ValvePrecision Transcatheter Option For US Heart Patients - AD HOC NEWS
Form 4 Edwards Lifesciences Corp For: 7 July By Investing.com - Investing.com South Africa
Edwards Lifesciences’ SWOT analysis: stock gains momentum on market share opportunity - Investing.com
Edwards Lifesciences (EW) executive has shares withheld for tax on vesting - Stock Titan
Edwards Lifesciences highlights structural heart portfolio as investors track long-term growth prosp - ad-hoc-news.de
Edwards Lifesciences Investors Seek 1st OK For $39M Deal - Law360
EWEdwards Lifesciences Corp Latest SEC Filings - Finviz
EW Maintained by Evercore ISI Group -- Price Target Raised to $1 - GuruFocus
Edwards Lifesciences Corp (EW): Analyst Consensus Points to Growth Potential in the Medical Device Sector - DirectorsTalk Interviews
Edwards Lifesciences stock leans on its core heart valve business - ad-hoc-news.de
Law firm investigates Edwards Lifesciences offi... - Pluang
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? - marketscreener.com
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MSN
TD Cowen Names Edwards Lifesciences as Top Medical Device Pick By Investing.com - Investing.com Nigeria
TD Cowen Names Edwards Lifesciences as Top Medical Device Pick - Investing.com
Edwards Lifesciences stock hits 52-week high at 92.94 USD By Investing.com - Investing.com Nigeria
Edwards Lifesciences stock hits 52-week high at 92.94 USD - Investing.com
What You Need To Know Ahead of Edwards Lifesciences' Earnings Release - Yahoo Finance
Edwards Lifesciences highlights heart valve portfolio as investors watch long-term growth - AD HOC NEWS
Insider Sell Alert: Daniel Lippis Sells Shares of Edwards Lifesc - GuruFocus
Edwards Lifesciences CVP Daniel Lippis sells $56k in stock By Investing.com - Investing.com Nigeria
Form 4 Edwards Lifesciences Corp For: 30 June By Investing.com - Investing.com Canada
TAX MANAGED MULTI CAP GROWTH PORTFOLIO's Edwards Lifesciences Corp(EW) Holding History - GuruFocus
Edwards Lifesciences CVP Daniel Lippis sells $56k in stock - Investing.com
Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan - Stock Titan
BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Edwards Lifesciences (EW) Gains FDA Approval for Ecliptis System - GuruFocus
Edwards Lifesciences Wins FDA Clearance for ECLIPTIS LAA System - Medical Device and Diagnostic industry
0.27%
0.94%
자본화:
|
볼륨(24시간):